These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35367971)

  • 1. Immunogenetic Determinants of Parkinson's Disease Etiology.
    Kung PJ; Elsayed I; Reyes-Pérez P; Bandres-Ciga S
    J Parkinsons Dis; 2022; 12(s1):S13-S27. PubMed ID: 35367971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Perspectives on Immune Involvement in Parkinson's Disease Pathogenesis.
    Gate D
    J Parkinsons Dis; 2022; 12(s1):S5-S11. PubMed ID: 35811535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of monogenic genes in idiopathic Parkinson's disease.
    Reed X; Bandrés-Ciga S; Blauwendraat C; Cookson MR
    Neurobiol Dis; 2019 Apr; 124():230-239. PubMed ID: 30448284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-related biomarkers for Parkinson's disease.
    Abdi IY; Ghanem SS; El-Agnaf OM
    Neurobiol Dis; 2022 Aug; 170():105771. PubMed ID: 35598675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBA1 and The Immune System: A Potential Role in Parkinson's Disease?
    Al-Azzawi ZAM; Arfaie S; Gan-Or Z
    J Parkinsons Dis; 2022; 12(s1):S53-S64. PubMed ID: 36057834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inflammation in sporadic and familial Parkinson's disease.
    Deleidi M; Gasser T
    Cell Mol Life Sci; 2013 Nov; 70(22):4259-73. PubMed ID: 23665870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 as a target for modulating immune system responses.
    Russo I; Bubacco L; Greggio E
    Neurobiol Dis; 2022 Jul; 169():105724. PubMed ID: 35427743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
    Hatano T; Kubo S; Sato S; Hattori N
    J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk factors in Parkinson's disease.
    Billingsley KJ; Bandres-Ciga S; Saez-Atienzar S; Singleton AB
    Cell Tissue Res; 2018 Jul; 373(1):9-20. PubMed ID: 29536161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses in Parkinson's disease: interplay between central and peripheral immune systems.
    Su X; Federoff HJ
    Biomed Res Int; 2014; 2014():275178. PubMed ID: 24822191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease].
    Hattori N; Kubo S
    Rinsho Shinkeigaku; 2007 Nov; 47(11):774-8. PubMed ID: 18210796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a Global View of Parkinson's Disease Genetics.
    Khani M; Cerquera-Cleves C; Kekenadze M; Wild Crea P; Singleton AB; Bandres-Ciga S
    Ann Neurol; 2024 May; 95(5):831-842. PubMed ID: 38557965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What genetics tells us about the causes and mechanisms of Parkinson's disease.
    Corti O; Lesage S; Brice A
    Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation in Parkinson's Disease: Triggers, Mechanisms, and Immunotherapies.
    Wang T; Shi C; Luo H; Zheng H; Fan L; Tang M; Su Y; Yang J; Mao C; Xu Y
    Neuroscientist; 2022 Aug; 28(4):364-381. PubMed ID: 33576313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M1 and M2 immune activation in Parkinson's Disease: Foe and ally?
    Moehle MS; West AB
    Neuroscience; 2015 Aug; 302():59-73. PubMed ID: 25463515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives.
    Magistrelli L; Ferrari M; Furgiuele A; Milner AV; Contaldi E; Comi C; Cosentino M; Marino F
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease.
    Contaldi E; Magistrelli L; Comi C
    Handb Clin Neurol; 2023; 193():67-93. PubMed ID: 36803824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage and repair in Parkinson's disease: Recent advances and new opportunities.
    Gonzalez-Hunt CP; Sanders LH
    J Neurosci Res; 2021 Jan; 99(1):180-189. PubMed ID: 32048327
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.